Epivax Oncology is a providence, RI and NY-based precision cancer immunotherapy company.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Providence
State: Rhode Island
Zip:
Country: United States
EpiVax Oncology is a provider of a clinical research and development platform intended to offer various type of precision cancer immunotherapies. The company&s;s platform are based on optimal neo-epitopes selected through its proprietary and validated, in-silico, predictive algorithms, enabling clients to address the unmet medical needs that are inadequately addressed by current cancer therapeutic approaches.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2018 | Venture Round | $0 |
Accelerate New York Seed Fund Horatio Ventures NYC Morningside Venture Partners NextWaveBio Accelerate New York Seed Fund Horatio Ventures NYC Morningside Venture Partners NextWaveBio |
5/2018 | Grant | 1 | $325k |
National Institutes of Health National Institutes of Health |
6/2018 | Venture Round | 4 | $1.2M |
Accelerate New York Seed Fund Horatio Ventures NYC Morningside Venture Partners NextWaveBio Accelerate New York Seed Fund Horatio Ventures NYC Morningside Venture Partners NextWaveBio |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|